- Home
- ALVO vs TWST Comparison
ALVO vs TWST Comparison
Compare ALVO & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | TWST |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALVO | TWST |
|---|---|---|
| Price | $5.11 | $31.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $10.67 | ★ $47.50 |
| AVG Volume (30 Days) | 820.8K | ★ 1.9M |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $573,350,000.00 | $376,572,000.00 |
| Revenue This Year | $34.94 | $17.89 |
| Revenue Next Year | $39.55 | $16.81 |
| P/E Ratio | $21.24 | ★ N/A |
| Revenue Growth | ★ 45.55 | 20.32 |
| 52 Week Low | $4.70 | $23.30 |
| 52 Week High | $13.70 | $55.33 |
Technical Indicators
Market Signals| Indicator | ALVO | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 33.90 | 56.90 |
| Support Level | $5.05 | $25.67 |
| Resistance Level | $5.49 | $27.37 |
| Average True Range (ATR) | 0.28 | 1.95 |
| MACD | 0.08 | 0.33 |
| Stochastic Oscillator | 6.87 | 95.62 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.